MAPLE ACCESS PARTNERSHIP LLP
MAPLE HOUSE, 17-19 HAZELWOOD ROAD, NORTHAMPTONCHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 21 | 22 | 95.5% | |
CHD 9 | 2006 | 34 | 35 | 97.1% | |
CHD 9 | 2007 | 34 | 35 | 97.1% | |
CHD 9 | 2008 | 44 | 46 | 95.7% | |
CHD 9 | 2009 | 45 | 46 | 97.8% | |
CHD 9 | 2010 | 42 | 46 | 91.3% | |
CHD 9 | 2011 | 45 | 46 | 97.8% | |
CHD 9 | 2012 | 48 | 50 | 96.0% | |
CHD 9 | 2013 | 46 | 51 | 90.2% | |
CHD005 | 2014 | 61 | 62 | 98.4% | |
CHD005 | 2015 | 70 | 70 | 100.0% | |
CHD005 | 2016 | 91 | 97 | 93.8% | |
CHD005 | 2017 | 98 | 98 | 100.0% | |
CHD005 | 2018 | 100 | 101 | 99.0% | |
CHD005 | 2019 | 109 | 111 | 98.2% | |
CHD005 | 2020 | 120 | 120 | 100.0% | |
CHD005 | 2021 | 123 | 146 | 84.2% | |
CHD005 | 2022 | 131 | 134 | 97.8% | |
CHD005 | 2023 | 133 | 134 | 99.3% |